Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

Adobe (ADBE +2.70%) is fighting tooth and nail to remain relevant in the era of artificial intelligence (AI). Adobe makes ...

One reason is obvious, while the other one isn't exactly difficult to believe. For the better part of the past couple of ...

Nvidia (NVDA +4.30%) became the world's most valuable company because it is a critical part of the AI build-out. Companies ...

Tesla now expects capital expenditures to exceed $25 billion in 2026, the company said during its first-quarter earnings call ...

Nike and Lululemon Athletica have established brands, but is that enough to warrant a forever place in your portfolio?

Last week started on an inauspicious note for industrial parts manufacturer Mueller Industries (MLI +0.21%). Shares ended ...

The catalysts for a further gold rally are still in place. But if you're looking for a gold ETF to buy, make sure you're ...

The e-commerce and cloud computing giant's recent $25 billion investment plan in Anthropic captures its aggressive push into ...

Etsy's fall from grace can be blamed on weak trends in the core marketplace's gross merchandise sales (GMS), a measure of the ...

Poet Technologies ( POET +28.84%) stock posted massive gains this week. The optics-technologies specialist's share price ...

Here's what the rest of the year could look like. The market has gone from focusing almost entirely on the AI trade to now ...